Novo taps e-therapeutics for diabetes target discovery drive

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 11, 2018 at 10:32 AM.

  1. #1 cafead, Dec 11, 2018 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Novo Nordisk has enlisted e-therapeutics to support target discovery efforts at its recently opened research center in Oxford, U.K. The collaboration will see e-therapeutics apply its platform for finding synergistic target combinations to a “specific area” of Type 2 diabetes.

    article source
     
    Quote

Reply to Thread